SLB N.V. (LON:0SCL)
37.01
+0.60 (1.65%)
At close: Nov 14, 2025
SLB N.V. Revenue
SLB N.V. had revenue of $8.93B USD in the quarter ending September 30, 2025, a decrease of -2.52%. This brings the company's revenue in the last twelve months to $35.25B, down -2.08% year-over-year. In the year 2024, SLB N.V. had annual revenue of $36.29B with 9.52% growth.
Revenue (ttm)
$35.25B
Revenue Growth
-2.08%
P/S Ratio
1.56
Revenue / Employee
$320.43K
Employees
110,000
Market Cap
40.98B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 36.29B | 3.15B | 9.52% |
| Dec 31, 2023 | 33.14B | 5.04B | 17.96% |
| Dec 31, 2022 | 28.09B | 5.16B | 22.51% |
| Dec 31, 2021 | 22.93B | -672.00M | -2.85% |
| Dec 31, 2020 | 23.60B | -9.32B | -28.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |